Standard Biotools (NASDAQ:LAB) is a company engaged in the design, development, and commercialization of tools for the life sciences community. Its operations span across the development of innovative technologies and systems that enable genomic and cell biology research, aiming to contribute to breakthroughs in scientific understanding and medical research. Standard Biotools focuses on delivering high-quality solutions that meet the evolving needs of researchers and scientists in the biotechnological field. Their projects range from developing sophisticated instruments and consumables to providing comprehensive analytical software solutions. The company's objective is to accelerate scientific discovery by offering products that enhance the efficiency and effectiveness of laboratory research.